Long-Term Durability and Stability of Amlitelimab Efficacy in Adults With Moderate-to-Severe Atopic Dermatitis: 52-Week Post Hoc Analysis of the STREAM-AD Phase 2b Trial. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 Apr. 30];9(6):s607. Available from: https://skin.dermsquared.com/skin/article/view/3813